Putting agonist activity at all three receptors into a single molecule is a relatively new pharmacology, and retatrutide is the lead compound exploring it
Results This review is based on an integrative pathophysiological model derived from observational data, molecular biology, and extrapolations from related estrogen-dependent disorders
Current evidence from the European Medicines Agency and FDA does not establish a causal link between Wegovy and depression or suicidal thoughts, though regulatory authorities continue monitoring reports
This has opened up an exciting new field and, as always, mathematics is essential for the investigation and determination of underlying biological and medical mechanisms
Bedhomme, M
Drug design, development and therapy, 9, 24852499